Exploiting the measles vector platform for vaccines Interviewee/Contributor Erich Tauber Organisation Themis Bioscience GmbH Strategy Vaccine Read more about Exploiting the measles vector platform for vaccines
Convalescent plasma hope in SARS-CoV-2 crisis Interviewee/Contributor Peter Charlish Organisation MedNous Antibody Drug discovery Read more about Convalescent plasma hope in SARS-CoV-2 crisis
Biotechs fare relatively well amidst share collapse Interviewee/Contributor William Ellington Organisation MedNous Stock market performance Read more about Biotechs fare relatively well amidst share collapse
COVID-19's logistical impact on advanced therapies Interviewee/Contributor Matthew Lakelin Organisation TrakCel Ltd Gene therapy Strategy Read more about COVID-19's logistical impact on advanced therapies
Solving the viral vector bottleneck during a pandemic Interviewee/Contributor Géraldine Guérin-Peyrou Organisation Polyplus-transfection SA Gene therapy Strategy Read more about Solving the viral vector bottleneck during a pandemic
What patients really want: involvement Interviewee/Contributor Pierre Meulien Organisation Innovative Medicines Initiative Commentary Clinical trials Drug discovery Policy & Regulation Read more about What patients really want: involvement
Scientists and industry mobilise against coronavirus Interviewee/Contributor Victoria English Organisation MedNous Policy & Regulation Strategy Vaccine Read more about Scientists and industry mobilise against coronavirus
Late-stage oncology pipeline is robust Interviewee/Contributor Bruno Pagliara Organisation MedNous Cancer (Oncology) Clinical trials Read more about Late-stage oncology pipeline is robust
A meeting of minds at AstraZeneca Interviewee/Contributor José Baselga Organisation AstraZeneca Plc Cancer (Oncology) Drug discovery Strategy Read more about A meeting of minds at AstraZeneca
Groundbreaking genomic study of cancer published Interviewee/Contributor Peter Charlish Organisation MedNous Academic Research Cancer (Oncology) Read more about Groundbreaking genomic study of cancer published